Price Alert

Oruka Therapeutics Inc. (ORKA)

NASDAQ: ORKA · Real-Time Price · USD

14.58

-0.67 (-4.39%)

At close: Aug 19, 2025, 3:59 PM

14.56

-0.14%

After-hours: Aug 19, 2025, 05:13 PM EDT

Oruka Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Cash & Equivalents	65.4M	83.57M	61.58M	410.88M	33.28M	27.74M	37.43M	38.49M	40.16M	40.85M	42.45M	43.94M	46.44M	49.06M	53.36M	58.31M	63.2M	66.93M
Short-Term Investments	263.01M	265.52M	314.07M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	23.05M	23.95M	18.07M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	103K	103K	43K	43K	12K	488K	12K	12K	18K	18K	18K	18K	18K	18K	18K	18K	18K	12K
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	3.61M	2.99M	1.22M	2.07M	537K	n/a	161K	405K	599K	852K	254K	611K	1.22M	1.48M	1.06M	1.35M	1.6M	1.8M
Total Current Assets	332.01M	352.08M	376.87M	412.95M	33.82M	27.74M	37.59M	38.89M	40.76M	41.7M	42.7M	44.55M	47.66M	50.54M	54.42M	59.67M	64.79M	68.73M
Property-Plant & Equipment	2.25M	973K	1.04M	1.1M	12K	n/a	257K	280K	310K	339K	368K	397K	428K	457K	485K	508K	527K	441K
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	25.41M	25.03M	19.15M	1.14M	24K	488K	269K	292K	328K	357K	386K	415K	446K	475K	503K	526K	545K	453K
Total Assets	357.42M	377.11M	396.02M	414.09M	33.84M	28.23M	37.86M	39.18M	41.08M	42.06M	43.09M	44.97M	48.1M	51.01M	54.92M	60.19M	65.34M	69.18M
Account Payables	4.66M	3.54M	3.46M	8.5M	571K	5.9M	n/a	n/a	241K	366K	334K	593K	1.11M	1.01M	1.12M	1.13M	2.19M	1.58M
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	283K	213K	146K	24K	48K	76K	77K	86K	95K	103K	108K	106K	103K	100K	97K	87K	56K
Other Current Liabilities	4.77M	7.08M	7.33M	8.47M	567K	86K	461K	827K	1.08M	570K	522K	903K	1.27M	1.43M	1.36M	1.81M	1.22M	991K
Total Current Liabilities	12.11M	11.72M	13.04M	18.04M	1.27M	7.17M	637K	992K	1.6M	1.27M	1.13M	1.94M	2.81M	2.72M	3.5M	3.18M	3.69M	2.88M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	24.98M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	52.84M	n/a	3.15M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	1.67M	664K	755K	53.68M	n/a	28.13M	204K	224K	243K	262K	280K	301K	329K	357K	383K	410K	435K	394K
Total Liabilities	13.78M	12.39M	13.8M	71.72M	1.27M	35.29M	841K	1.22M	1.84M	1.53M	1.41M	2.24M	3.14M	3.08M	3.88M	3.59M	4.13M	3.27M
Total Debt	2.33M	947K	968K	988K	24K	24.98M	280K	301K	329K	357K	383K	409K	435K	460K	483K	507K	522K	450K
Common Stock	37K	37K	37K	35K	14K	1K	14K	14K	14K	14K	14K	14K	14K	14K	14K	14K	14K	14K
Retained Earnings	-129.3M	-104.72M	-83.72M	-57.94M	-193.43M	-7.08M	-188.74M	-187.65M	-186.23M	-184.75M	-183.4M	-182.23M	-179.9M	-176.75M	-173.48M	-167.8M	-163.09M	-158.25M
Comprehensive Income	-27K	-6K	-41K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Shareholders Equity	343.64M	364.73M	382.22M	342.37M	32.57M	-7.06M	37.02M	37.97M	39.24M	40.53M	41.67M	42.73M	44.96M	47.94M	51.04M	56.6M	61.21M	65.91M
Total Investments	286.06M	289.48M	332.14M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a